Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Microenvironment‐Responsive Dual Drug Dimer‐Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune‐Chemotherapy of Breast Cancer
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 1901896
Publisher
Wiley
Online
2019-06-06
DOI
10.1002/adfm.201901896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced Tumor Retention Effect by Click Chemistry for Improved Cancer Immunochemotherapy
- (2018) Ling Mei et al. ACS Applied Materials & Interfaces
- Coadministration of iRGD with Multistage Responsive Nanoparticles Enhanced Tumor Targeting and Penetration Abilities for Breast Cancer Therapy
- (2018) Chuan Hu et al. ACS Applied Materials & Interfaces
- Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy
- (2018) Qing Pei et al. ACS Nano
- Nanoparticles of Chlorin Dimer with Enhanced Absorbance for Photoacoustic Imaging and Phototherapy
- (2018) Xiaohua Zheng et al. ADVANCED FUNCTIONAL MATERIALS
- SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy
- (2018) Jordan A. Naumann et al. BIOCONJUGATE CHEMISTRY
- Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
- (2018) Chuan Hu et al. BIOMATERIALS
- Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis
- (2018) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- High Drug Loading and Sub-Quantitative Loading Efficiency of Polymeric Micelles Driven by Donor–Receptor Coordination Interactions
- (2018) Shixian Lv et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Efficacy of inverso isomer of CendR peptide on tumor tissue penetration
- (2018) Ruifeng Wang et al. Acta Pharmaceutica Sinica B
- Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy
- (2018) Xi He et al. ACS Applied Materials & Interfaces
- Methotrexate-loaded nitrogen-doped graphene quantum dots nanocarriers as an efficient anticancer drug delivery system
- (2017) Fatemeh Khodadadei et al. Materials Science & Engineering C-Materials for Biological Applications
- Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
- (2017) Shu Yang et al. PHARMACOLOGICAL RESEARCH
- Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
- (2016) Shaobo Ruan et al. ACS Nano
- Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy
- (2016) Yonghyun Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mechanism of antineoplastic activity of lonidamine
- (2016) Kavindra Nath et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Self-Assembled ROS-Sensitive Polymer–Peptide Therapeutics Incorporating Built-in Reporters for Evaluation of Treatment Efficacy
- (2016) Zeng-Ying Qiao et al. BIOMACROMOLECULES
- Polymeric nanoparticles for targeted drug delivery system for cancer therapy
- (2016) Farha Masood Materials Science & Engineering C-Materials for Biological Applications
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer
- (2016) Yizhuo Wang et al. Cancer Medicine
- A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration
- (2015) Xingli Cun et al. ACS Applied Materials & Interfaces
- Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors
- (2015) Cassandra E. Callmann et al. ADVANCED MATERIALS
- Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment
- (2015) Assogba G. Assanhou et al. BIOMATERIALS
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency
- (2015) Kaimin Cai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-assembly of BODIPY based pH-sensitive near-infrared polymeric micelles for drug controlled delivery and fluorescence imaging applications
- (2015) Xiaodong Liu et al. Nanoscale
- PEG — A versatile conjugating ligand for drugs and drug delivery systems
- (2014) Atul Kolate et al. JOURNAL OF CONTROLLED RELEASE
- Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines
- (2014) Yongjun Wang et al. NANO LETTERS
- Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin
- (2014) Kavindra Nath et al. NMR IN BIOMEDICINE
- Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways
- (2013) Nan Li et al. BIOMATERIALS
- Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
- (2013) Vaskor Bala et al. JOURNAL OF CONTROLLED RELEASE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- 31P and1H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan
- (2012) Kavindra Nath et al. NMR IN BIOMEDICINE
- Hsp90 inhibitors and drug resistance in cancer: The potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs
- (2011) Xiangyi Lu et al. BIOCHEMICAL PHARMACOLOGY
- Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration
- (2011) Emilie Roger et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
- (2010) Hiroshi Maeda BIOCONJUGATE CHEMISTRY
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
- (2010) Chrystelle Brignone et al. Journal of Translational Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started